Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): Management with l-ornithine-l-aspartate and stent reduction

被引：0

作者：

Vanessa Stadlbauer

Josef Tauss

Horst R. Portugaller

Philipp Stiegler

Florian Iberer

Rudolf E. Stauber

机构：

[1] Medical University of Graz,Department of Internal Medicine, Division of Gastroenterology and Hepatology

[2] Medical University of Graz,Department of Radiology, Division of Interventional Radiology

[3] Medical University of Graz,Department of Surgery, Division of Transplantation Surgery

[4] University College London,Department of Medicine, Liver Failure Group, UCL Institute of Hepatology

来源：

Metabolic Brain Disease | 2007年 / 22卷

关键词：

Hepatic encephalopathy; Venous ammonia levels; Transjugular intrahepatic portosystemic shunt; -ornithine-; -aspartate; Stent reduction;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Hepatic encephalopathy (HE) is a common problem after insertion of a trans-jugular intrahepatic portosystemic shunt (TIPS), which may be difficult to manage. We present a case of severe post-TIPS HE unresponsive to high doses of l-ornithine-l-aspartate (LOLA) despite reduction of venous ammonia levels in a dose-dependent fashion. Ultimately, high-grade HE was successfully treated by a reduction stent and the patient subsequently underwent successful liver transplantation.

引用

页码：45 / 50

页数：5

共 50 条

[21] Reversal of hemolytic anemia and hepatic encephalopathy by transjugular intrahepatic portosystemic shunt occlusion
Sindhu A. Abraham
Current Treatment Options in Gastroenterology, 2000, 3 (2) : 105 - 109
[22] Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt-TIPS, and strategies to improve the outcomes
Berenguer, M.
ACTA GASTRO-ENTEROLOGICA BELGICA, 2023, 86 (02) : 318 - 322
[23] Symptomatic hepatic hydrothorax successfully treated with transjugular intrahepatic portosystemic shunt (TIPS)-role of titration of portosystemic gradient reduction to avoid postTIPS encephalopathy
Krishnamoorthy, T. L.
Taneja, M.
Chang, P. E.
CLINICAL CASE REPORTS, 2014, 2 (03): : 93 - 97
[24] Current state of knowledge of hepatic encephalopathy (Part V): clinical efficacy of L-ornithine-L-aspartate in the management of HE
Gerald Kircheis
Metabolic Brain Disease, 2016, 31 : 1365 - 1367
[25] Current state of knowledge of hepatic encephalopathy (Part V): clinical efficacy of L-ornithine-L-aspartate in the management of HE
Kircheis, Gerald
METABOLIC BRAIN DISEASE, 2016, 31 (06) : 1365 - 1367
[26] Application of fecal microbial transplantation in hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
Li, Jun
Wang, Dan
Sun, Jingping
MEDICINE, 2022, 101 (03)
[27] Preoperative prediction of overt hepatic encephalopathy caused by transjugular intrahepatic portosystemic shunt
Yang, Yang
Liang, Xueqing
Yang, Shirui
He, Xiaofeng
Huang, Mingsheng
Shi, Wenfeng
Luo, Junyang
Duan, Chongyang
Feng, Xinghui
Fu, Sirui
Lu, Ligong
EUROPEAN JOURNAL OF RADIOLOGY, 2022, 154
[28] Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS)
Sturm, Lukas
Bettinger, Dominik
Giesler, Max
Boettler, Tobias
Schmidt, Arthur
Buettner, Nico
Thimme, Robert
Schultheiss, Michael
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2018, 6 (09) : 1380 - 1390
[29] Coaxial Stent Graft inside a Constraining Stent for Transjugular Intrahepatic Portosystemic Shunt Reduction
Ronald, James
Kim, Charles Y.
Konanur, Meghana
Dai, Rui
Befera, Nicholas
Knutson, James
Cline, Brendan C.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2022, 33 (12) : 1513 - +
[30] l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials
Bai, Ming
Yang, Zhiping
Qi, Xingshun
Fan, Daiming
Han, Guohong
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (05) : 783 - 792

← 1 2 3 4 5 →